Kalshi is Betting on Trial Results and FDA Decisions Now, What's Next?
FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials
Evis Sala Announces a Landmark Oncology Partnership Between Albania and Italy
RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer
Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine
First Chemotherapy Session: What to Expect
SABCS 2026 Male Breast Cancer Advocate Scholarship
Herbert Loong: Prospective Open-labelled Phase 2 Pembrolizumab in Acral Lentiginous Melanoma
The NCI Data Jamboree: Enhancing Data Sharing and Utility to Advance Cancer Research, organized by the National Cancer Institute (NCI) will take place on 16–18 November 2026 at the NIH […]
The 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) is scheduled to take place in person from November 18–20, 2026, at the CCIB (Centre de Convencions Internacional […]
